Log in
NYSE:FMS

Fresenius Medical Care AG & Co. Stock Forecast, Price & News

$41.72
+0.15 (+0.36 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$41.01
Now: $41.72
$41.89
50-Day Range
$41.37
MA: $42.65
$43.51
52-Week Range
$29.17
Now: $41.72
$46.55
Volume118,055 shs
Average Volume299,093 shs
Market Capitalization$24.89 billion
P/E Ratio17.24
Dividend Yield1.20%
Beta1.26
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2018, it operated 3,928 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Read More
Fresenius Medical Care AG & Co. logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 1.9Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.57 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone49-6172-608-2522

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$19.58 billion
Cash Flow$5.43 per share
Book Value$24.83 per share

Profitability

Net Income$1.34 billion

Miscellaneous

Employees120,659
Market Cap$24.89 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$41.72
+0.15 (+0.36 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FMS News and Ratings via Email

Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Fresenius Medical Care AG & Co. (NYSE:FMS) Frequently Asked Questions

How has Fresenius Medical Care AG & Co.'s stock been impacted by COVID-19?

Fresenius Medical Care AG & Co.'s stock was trading at $35.43 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, FMS shares have increased by 17.8% and is now trading at $41.72.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Fresenius Medical Care AG & Co.?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. in the last year. There are currently 4 hold ratings, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Fresenius Medical Care AG & Co.
.

When is Fresenius Medical Care AG & Co.'s next earnings date?

Fresenius Medical Care AG & Co. is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Fresenius Medical Care AG & Co.
.

How were Fresenius Medical Care AG & Co.'s earnings last quarter?

Fresenius Medical Care AG & Co. (NYSE:FMS) released its earnings results on Thursday, July, 30th. The company reported $0.66 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.54 by $0.12. The business earned $5.02 billion during the quarter, compared to analyst estimates of $5 billion. Fresenius Medical Care AG & Co. had a return on equity of 10.50% and a net margin of 7.26%.
View Fresenius Medical Care AG & Co.'s earnings history
.

How often does Fresenius Medical Care AG & Co. pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. declared an annual dividend on Thursday, August 13th. Stockholders of record on Monday, August 31st will be given a dividend of $0.7073 per share on Friday, September 11th. This represents a dividend yield of 1.64%. The ex-dividend date is Friday, August 28th. This is a positive change from Fresenius Medical Care AG & Co.'s previous annual dividend of $0.66.
View Fresenius Medical Care AG & Co.'s dividend history
.

What price target have analysts set for FMS?

13 analysts have issued twelve-month price targets for Fresenius Medical Care AG & Co.'s shares. Their forecasts range from $42.00 to $48.00. On average, they expect Fresenius Medical Care AG & Co.'s share price to reach $45.13 in the next year. This suggests a possible upside of 8.2% from the stock's current price.
View analysts' price targets for Fresenius Medical Care AG & Co.
.

Are investors shorting Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 363,200 shares, an increase of 13.9% from the August 31st total of 319,000 shares. Based on an average daily volume of 146,900 shares, the days-to-cover ratio is currently 2.5 days.
View Fresenius Medical Care AG & Co.'s Short Interest
.

Who are some of Fresenius Medical Care AG & Co.'s key competitors?

What other stocks do shareholders of Fresenius Medical Care AG & Co. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. investors own include Energy Transfer LP Unit (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

Who are Fresenius Medical Care AG & Co.'s key executives?

Fresenius Medical Care AG & Co.'s management team includes the following people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 64)
  • Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 64)
  • Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 60)
  • Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 47)
  • Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 57)

What is Fresenius Medical Care AG & Co.'s stock symbol?

Fresenius Medical Care AG & Co. trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Who are Fresenius Medical Care AG & Co.'s major shareholders?

Fresenius Medical Care AG & Co.'s stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Bank of America Corp DE (0.11%), Thornburg Investment Management Inc. (0.11%), Todd Asset Management LLC (0.06%), Goldman Sachs Group Inc. (0.05%), Teachers Retirement System of The State of Kentucky (0.04%) and Jarislowsky Fraser Ltd (0.03%).

Which major investors are selling Fresenius Medical Care AG & Co. stock?

FMS stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Goldman Sachs Group Inc., RBF Capital LLC, Jarislowsky Fraser Ltd, Stifel Financial Corp, US Bancorp DE, Raymond James & Associates, and Silvercrest Asset Management Group LLC.

Which major investors are buying Fresenius Medical Care AG & Co. stock?

FMS stock was acquired by a variety of institutional investors in the last quarter, including Todd Asset Management LLC, Teachers Retirement System of The State of Kentucky, Bank of New York Mellon Corp, Thornburg Investment Management Inc., Natixis Advisors L.P., Quantamental Technologies LLC, DC Investments Management LLC, and Fifth Third Bancorp.

How do I buy shares of Fresenius Medical Care AG & Co.?

Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Fresenius Medical Care AG & Co.'s stock price today?

One share of FMS stock can currently be purchased for approximately $41.72.

How big of a company is Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. has a market capitalization of $24.89 billion and generates $19.58 billion in revenue each year. The company earns $1.34 billion in net income (profit) each year or $2.53 on an earnings per share basis. Fresenius Medical Care AG & Co. employs 120,659 workers across the globe.

What is Fresenius Medical Care AG & Co.'s official website?

The official website for Fresenius Medical Care AG & Co. is www.freseniusmedicalcare.com.

How can I contact Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co.'s mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at 49-6172-608-2522 or via email at [email protected]

This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.